Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tuesday, July 13, 2010 - 9:14pm
tags:
BioSante, LibiGel, testosterone, EntreMed, ENMD-2076, cancer, Protalix BioTherapeutics, UPLYSO, ovarian cancer, Vivus, Qnexa, obesity, EMD 640744, cancer vaccines
KV’s Gestiva resubmitted to FDA
bizjournals
Tuesday, July 13, 2010 - 9:05pm
tags:
KV Pharmaceutical, Gestiva, preterm labor
Technical Analysis Alert for Teva Pharmaceutical Industries Limited (TEVA)
Market Intellisearch
Tuesday, July 13, 2010 - 9:03pm
tags:
Teva Pharmaceuticals
Pfizer’s growth outlook seen strong
Economic Times, India
Tuesday, July 13, 2010 - 9:01pm
tags:
Pfizer
OSI Pharmaceuticals Announces the Results of its Offer to Purchase its 2% Convertible Notes and a Change in the Expiration Time of its Offer to Purchase its 3% Convertible Notes
MarketWatch
Tuesday, July 13, 2010 - 8:58pm
tags:
OSI Pharmaceuticals
FDA Scientists Debate Results Of Glaxo Avandia Study
WSJ
Tuesday, July 13, 2010 - 8:55pm
tags:
GSK, Avandia, diabetes, FDA
ILNS has a big stake in the $20 billion Alzheimer's space
Small Cap Network
Tuesday, July 13, 2010 - 8:45pm
tags:
Intellect Neurosciences, Pfizer, JNJ, Alzheimer's disease
California Supreme Court reinstates price-fixing case against 20 drug companies
news10.net
Tuesday, July 13, 2010 - 8:41pm
tags:
price fixing
Glaxo Said to Pay $460 Million to Settle Avandia Damage Suits
Bloomberg
Tuesday, July 13, 2010 - 12:31pm
tags:
settlements, Avandia, GSK, diabetes
Charles River: Wuxi may add $100M to yearly sales
Yahoo/AP
Tuesday, July 13, 2010 - 12:29pm
tags:
Charles River Laboratories, M&A, WuXi PharmaTech
Guest Post: Advice for the New PhRMA President
InVivo
Tuesday, July 13, 2010 - 12:28pm
tags:
PhRMA
Eli Lilly will shed 170 jobs in manufacturing, quality control
Indianapolis Star, IN
Tuesday, July 13, 2010 - 12:19pm
tags:
Eli Lilly, layoffs, drug manufacturing
Avandia On Trial: Nissen's Prosecution
Forbes
Tuesday, July 13, 2010 - 12:18pm
tags:
Steven Nissen, GSK, FDA, Avandia
How Novartis Vaccines turned fear into function
Fierce Pharma
Tuesday, July 13, 2010 - 11:32am
tags:
Novartis, vaccines, Chiron
Human Genome Sciences signs supply deal for lupus drug Benlysta with Lonza
Yahoo/AP
Tuesday, July 13, 2010 - 11:17am
tags:
Human Genome, partnerships, Lonza, Benlysta
Target Date for Protalix Drug
Yahoo/Zacks.com
Tuesday, July 13, 2010 - 11:16am
tags:
Protalix BioTherapeutics, Gaucher disease, Ulypso
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tuesday, July 13, 2010 - 11:14am
tags:
obsesity, diet drugs, advisory panels, FDA, Qnexa, Vivus, Arena Pharmaceuticals, Contrave, Orexigen
PBMs Win A Big Court Ruling Over Disclosure
Pharmalot
Tuesday, July 13, 2010 - 9:33am
tags:
PBMs
Mass. medical gift law faces possible repeal
CNBC
Tuesday, July 13, 2010 - 9:28am
tags:
Massachusetts, physician gifts
Glaxo Begins Its Defense
Forbes
Tuesday, July 13, 2010 - 9:26am
tags:
GSK, Avandia, diabetes, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.